Cargando…
SDPS-23 CUMULATIVE TUMOR VOLUME THRESHOLD CORRELATES WITH NEUROCOGNITIVE IMPAIRMENT IN PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES
OBJECTIVE: To explore the basic situation of cognitive function in patients with initial state of brain metastasis and the potential factors affecting cognitive function, so as to find the critical value of cumulative tumor volume leading to cognitive dysfunction. METHODS: A total of 284 patients wh...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402384/ http://dx.doi.org/10.1093/noajnl/vdad070.079 |
_version_ | 1785084864671776768 |
---|---|
author | Zhen, Junjie Cao, Xiangyi Wen, Lei Wang, Hui Lai, Mingyao Cai, Linbo |
author_facet | Zhen, Junjie Cao, Xiangyi Wen, Lei Wang, Hui Lai, Mingyao Cai, Linbo |
author_sort | Zhen, Junjie |
collection | PubMed |
description | OBJECTIVE: To explore the basic situation of cognitive function in patients with initial state of brain metastasis and the potential factors affecting cognitive function, so as to find the critical value of cumulative tumor volume leading to cognitive dysfunction. METHODS: A total of 284 patients who were newly diagnosed with brain metastases and underwent cognitive testing before radiotherapy in Guangdong Sanjiu Brain Hospital from 2016 to 2022 were retrospectively analyzed. The basic demographic information of the patients, KPS at the time of initial diagnosis, the number of brain metastases, the cumulative tumor volume, and the cognitive function test data before treatment were organized. RESULTS: The cognitive impairment occurred in 100/284 patients (the criteria for cognitive impairment is that at least two of the eight sub-tests are less than 1.5 standard deviation or at least one is less than 2 standard deviations). Multivariate analysis showed that the number of tumors was not a factor in cognitive dysfunction. Age, gender, KPS, educational level, and cumulative tumor volume were risk factors affecting cognitive function. The cumulative tumor volume cut-off value for MOCA, HVLT-R immediate memory, HVLT-R delayed memory, VFT, TMT-A, and TMT-B cognitive impairment were 13.608, 13.125, 11.070, 14.523, 11.070, and 11.113 cc, respectively, while cut-off value for SDMT and TOL were 5.435 and 4.528 cc, respectively. CONCLUSIONS: Before treatment, cognitive impairment of brain metastases had no significant correlation with the number of metastases but had a significant correlation with the cumulative tumor volume. The cumulative tumor volume cut-off value involving overall cognitive dysfunction, memory dysfunction, speech dysfunction, and decreased thinking speed is between 11-14.5 cc, and the cumulative tumor volume critical threshold involving executive dysfunction and computational dysfunction is between 4.5-5.5 cc. |
format | Online Article Text |
id | pubmed-10402384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-104023842023-08-05 SDPS-23 CUMULATIVE TUMOR VOLUME THRESHOLD CORRELATES WITH NEUROCOGNITIVE IMPAIRMENT IN PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES Zhen, Junjie Cao, Xiangyi Wen, Lei Wang, Hui Lai, Mingyao Cai, Linbo Neurooncol Adv Final Category: Screening/Diagnostics/Prognostics OBJECTIVE: To explore the basic situation of cognitive function in patients with initial state of brain metastasis and the potential factors affecting cognitive function, so as to find the critical value of cumulative tumor volume leading to cognitive dysfunction. METHODS: A total of 284 patients who were newly diagnosed with brain metastases and underwent cognitive testing before radiotherapy in Guangdong Sanjiu Brain Hospital from 2016 to 2022 were retrospectively analyzed. The basic demographic information of the patients, KPS at the time of initial diagnosis, the number of brain metastases, the cumulative tumor volume, and the cognitive function test data before treatment were organized. RESULTS: The cognitive impairment occurred in 100/284 patients (the criteria for cognitive impairment is that at least two of the eight sub-tests are less than 1.5 standard deviation or at least one is less than 2 standard deviations). Multivariate analysis showed that the number of tumors was not a factor in cognitive dysfunction. Age, gender, KPS, educational level, and cumulative tumor volume were risk factors affecting cognitive function. The cumulative tumor volume cut-off value for MOCA, HVLT-R immediate memory, HVLT-R delayed memory, VFT, TMT-A, and TMT-B cognitive impairment were 13.608, 13.125, 11.070, 14.523, 11.070, and 11.113 cc, respectively, while cut-off value for SDMT and TOL were 5.435 and 4.528 cc, respectively. CONCLUSIONS: Before treatment, cognitive impairment of brain metastases had no significant correlation with the number of metastases but had a significant correlation with the cumulative tumor volume. The cumulative tumor volume cut-off value involving overall cognitive dysfunction, memory dysfunction, speech dysfunction, and decreased thinking speed is between 11-14.5 cc, and the cumulative tumor volume critical threshold involving executive dysfunction and computational dysfunction is between 4.5-5.5 cc. Oxford University Press 2023-08-04 /pmc/articles/PMC10402384/ http://dx.doi.org/10.1093/noajnl/vdad070.079 Text en © The Author(s) 2023. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Final Category: Screening/Diagnostics/Prognostics Zhen, Junjie Cao, Xiangyi Wen, Lei Wang, Hui Lai, Mingyao Cai, Linbo SDPS-23 CUMULATIVE TUMOR VOLUME THRESHOLD CORRELATES WITH NEUROCOGNITIVE IMPAIRMENT IN PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES |
title | SDPS-23 CUMULATIVE TUMOR VOLUME THRESHOLD CORRELATES WITH NEUROCOGNITIVE IMPAIRMENT IN PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES |
title_full | SDPS-23 CUMULATIVE TUMOR VOLUME THRESHOLD CORRELATES WITH NEUROCOGNITIVE IMPAIRMENT IN PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES |
title_fullStr | SDPS-23 CUMULATIVE TUMOR VOLUME THRESHOLD CORRELATES WITH NEUROCOGNITIVE IMPAIRMENT IN PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES |
title_full_unstemmed | SDPS-23 CUMULATIVE TUMOR VOLUME THRESHOLD CORRELATES WITH NEUROCOGNITIVE IMPAIRMENT IN PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES |
title_short | SDPS-23 CUMULATIVE TUMOR VOLUME THRESHOLD CORRELATES WITH NEUROCOGNITIVE IMPAIRMENT IN PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES |
title_sort | sdps-23 cumulative tumor volume threshold correlates with neurocognitive impairment in patients with newly diagnosed brain metastases |
topic | Final Category: Screening/Diagnostics/Prognostics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402384/ http://dx.doi.org/10.1093/noajnl/vdad070.079 |
work_keys_str_mv | AT zhenjunjie sdps23cumulativetumorvolumethresholdcorrelateswithneurocognitiveimpairmentinpatientswithnewlydiagnosedbrainmetastases AT caoxiangyi sdps23cumulativetumorvolumethresholdcorrelateswithneurocognitiveimpairmentinpatientswithnewlydiagnosedbrainmetastases AT wenlei sdps23cumulativetumorvolumethresholdcorrelateswithneurocognitiveimpairmentinpatientswithnewlydiagnosedbrainmetastases AT wanghui sdps23cumulativetumorvolumethresholdcorrelateswithneurocognitiveimpairmentinpatientswithnewlydiagnosedbrainmetastases AT laimingyao sdps23cumulativetumorvolumethresholdcorrelateswithneurocognitiveimpairmentinpatientswithnewlydiagnosedbrainmetastases AT cailinbo sdps23cumulativetumorvolumethresholdcorrelateswithneurocognitiveimpairmentinpatientswithnewlydiagnosedbrainmetastases |